Sign in
8-K

Current Report

X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-027303

Material agreement · New debt or obligation · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.03 Creation of a direct financial obligation
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading xfor-20230802.htm…